Get Details

Jake Simson, Ph.D.

Jake represents RA Capital Management on the Board of Directors.

Jake Simson is a Partner at RA Capital Management. Jake works on both public and private investments and serves as a Board Director for Xenikos, B.V, Tyra Biosciences, AavantiBio, and DiCE Molecules. Previously, Jake covered solid tumor oncology landscapes. Jake holds a B.S. in materials science and engineering from MIT and a Ph.D. in biomedical engineering from Johns Hopkins University. In his doctoral research, he investigated clinically translatable treatments for musculoskeletal tissue repair using injectable hydrogels.

Let’s do some great work together to bring game-changing medicines to patients.